1.
Hepatology Communications
@HepCommJournal
1/15 NEW PUBLICATION OUT
Our group's new paper, published in Hepatology Communications, official journal of the… twitter.com/i/web/status/1…
Our group's new paper, published in Hepatology Communications, official journal of the… twitter.com/i/web/status/1…
Retweet of status by @theliverdr
2.
Hepatology Communications
@HepCommJournal
Non-Invasive Tests (NITs) for NAFLD in a Multi-Ethnic Population
Steatosis was
Different ethnicities ha… twitter.com/i/web/status/1…
Steatosis was
Different ethnicities ha… twitter.com/i/web/status/1…
3.
4.
5.
6.
7.
Hepatology Communications
@HepCommJournal
Psychosocial assessment in LT: an analysis of short-term outcomes
Listed patients with ALD had MELD and ps… twitter.com/i/web/status/1…
Listed patients with ALD had MELD and ps… twitter.com/i/web/status/1…
Hepatology Communications
@HepCommJournal
Another great year at HepComm!Thank you to each author for their contributions to the field of Hepatology!… twitter.com/i/web/status/1…
Hepatology Communications
@HepCommJournal
Risk of nonalcoholic fatty liver disease and associations with gastrointestinal cancers
@HepCommJournal… twitter.com/i/web/status/1…
@HepCommJournal… twitter.com/i/web/status/1…
Retweet of status by @ArndtVogel
Hepatology Communications
@HepCommJournal
Just published in @HepCommJournal: Differential expression of hepatic #cancer stemness & hypoxia markers in resi… twitter.com/i/web/status/1…
Retweet of status by @NancyReau
Hepatology Communications
@HepCommJournal
Antifibrotic effect and long-term outcome of #SGLT2 inhibitors in patients with #NAFLD complicated by diabetes me… twitter.com/i/web/status/1…
8.
9.
10.
11.
Hepatology Communications
@HepCommJournal
#Bile acid conjugation deficiency causes hypercholanemia, hyperphagia, islet dysfunction, and gut dysbiosis in mi… twitter.com/i/web/status/1…
Hepatology Communications
@HepCommJournal
HIBA score is an easy-to-use, reliable, reproducible, objective tool with excellent discriminatory capacity… twitter.com/i/web/status/1…
Hepatology Communications
@HepCommJournal
GAF4 criteria = low risk for #HCC recurrence following SVR after #HCV treatment
1- GGT < 28 IU/L
2- AFP < 4.0 n… twitter.com/i/web/status/1…
1- GGT < 28 IU/L
2- AFP < 4.0 n… twitter.com/i/web/status/1…
Hepatology Communications
@HepCommJournal
NEW PUB ALERT
FMT capsules to treat hepatic encephalopathy
aasldpubs.onlinelibrary.wiley.com/doi/10.1002/he…
Read to find out
Whi… twitter.com/i/web/status/1…
FMT capsules to treat hepatic encephalopathy
aasldpubs.onlinelibrary.wiley.com/doi/10.1002/he…
Read to find out
Whi… twitter.com/i/web/status/1…
...but wait! There's more!
1.
fakhright
@fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
